A recent metanalysis by researchers from Trinity College Dublin indicates an association between low circulating levels of vitamin D and mortality from COVID-19, and has doctors calling the government to increase the recommended daily intake for vitamin D across the continent.
Computer learning algorithms can now learn to distinguish different types of blood clots based on what caused them, says a new study.
A new research letter has found declines in rural areas have not been as pronounced as declines in metropolitan areas.
New research suggests a group of 6 cancer biomarkers was associated with all-cause mortality and HF hospitalizations.
The latest scientific statement from the association highlights the importance of healthy diet at a young age on preventing CVD later in life.
Researchers from the Mount Sinai COVID Informatics Center report improved survival rates in COVID patients treated with anticoagulants. Results of the study demonstrated that hospitalized COVID-19 patients treated with anticoagulants had improved outcomes both in and out of the intensive care unit setting, without a significant difference in bleeding.
Discussing the impact of high-intensity statin therapy on patients with dry AMD with a study investigator from Byers Eye Institute.
New data from Mount Sinai Hospital suggests anticoagulant use could improve survival rates among patients hospitalized with COVID-19.
After receiving approval for a similar indication in type 2 diabetics in late 2019, the FDA has approved dapagliflozin for reducing risk of CV death and hospitalization in patients with HFrEF.
A new analysis of two-year data from the FOURIER trial is shedding light on the impact of PCSK9 use for lowering LDL-C.
A new study from investigators in Finland found a single-lead ECG in a necklace could aid in diagnosis of AF.
A 17-year-old teen went to the ED after suffering his second syncopal episode in the last 6 months. He had shrugged off the first episode as not eating enough before a jog, but this time he hadn’t been doing anything active and his parents witnessed the syncope and what appeared to be a seizure. He reported that he had been feeling heart palpitations prior to the event. Further blood tests showed hypokalemia.
New research suggests an SBP target of 120 mmHg or less could lower risk of AFib up to 26%.
The latest scientific statement from the AHA addresses cardiovascular considerations before, during, and after pregnancy.
The AAN has released an update to their 2016 practice advisory—changing their stance on PFO closure to reduce risk of second stroke.
New research suggests childhood trauma and dysfunction could increase risk of CVD by up to 68%.
Evry will enable the imaging of COVID-19 patients in need of emergency care.
Patients who undergo emergency surgery have twice the risk for venous thromboembolism than those how have elective surgery.
An analysis of the CITU study is shedding light on the impact of e-cigarette use on arterial stiffness and vascular health.
A new analysis of the FOURIER trial is diving into whether evolocumab use could slow or prevent progression of aortic stenosis.
Australian researchers have new evidence that patients with diabetes have fewer cardiovascular events today than they did 20 years ago. The data came from an analysis of the Freemantle diabetes study which compared people with type 2 diabetes to people without diabetes. The results were recently published in the Journal of Clinical Endocrinology and Metabolism.
Australian researchers have new evidence that patients with diabetes have fewer cardiovascular events today than they did 20 years ago. The data came from an analysis of the Freemantle diabetes study which compared people with type 2 diabetes to people without diabetes. The results were recently published in the Journal of Clinical Endocrinology and Metabolism.
Since 2005, opioid use has increased amongst older dementia patients.
Results of the study from investigators at CHOP could have real-world impact on treatment algorithms.
A prespecified subanalysis revealed evolocumab use was associated with a significant reduction in risk of MI.
